8 important updates for Brain Cancer Awareness Month

May is Brain Cancer Awareness Month.

In conjunction with the observance, Healio provides the following updates on neuro-oncology research and treatment advances.

Younger patients with diffuse midline glioma experienced prolonged clinical improvement after receiving an investigational chimeric antigen receptor T-cell therapy. Read more.
Surgeons at Lenox Hill Hospital are recruiting patients for a first-in-human clinical trial to investigate the safety and feasibility of using belly fat to treat recurrent glioblastoma. Read more.
A personalized cancer vaccine conferred a PFS benefit to a subset of patients with newly diagnosed glioblastoma. Read more.
A retrospective observational study provided new insights into end-of-life care experiences for patients with intracranial high-grade gliomas. Read more.
Patients with isocitrate dehydrogenase wild-type glioblastoma who used levetiracetam for the duration of chemoradiation may achieve longer OS. Read more.
Results of early clinical trials suggest that chimeric antigen receptor T cells can be adapted successfully to target brain tumors. Read more.
The FDA awarded 11 grants worth more than $25 million to fund clinical trials of medical products intended to treat patients with rare diseases. The grants provide funding for three studies of brain cancer treatments. Read more.
In this version of Point/Counter, two clinicians debate whether proton therapy has a role in the treatment of brain tumors. Read more.

Published by:

Collapse

Source:

Healio Coverage

Related Content